Evidence map›Paper›PMID 38778541›Full record

ArticleBiophysical journal2024

The molecular basis for hydrodynamic properties of PEGylated human serum albumin.

Patrick J Fleming, John J Correia, Karen G Fleming

Abstract read
In one paragraph

Article in Biophysical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Patrick J FlemingThomas C. Jenkins Department of Biophysics, Johns Hopkins University, Baltimore, Maryland.
John J CorreiaDepartment of Cell and Molecular Biology, University of Mississippi Medical Center, Jackson, Mississippi.
Karen G FlemingThomas C. Jenkins Department of Biophysics, Johns Hopkins University, Baltimore, Maryland. Electronic address: karen.fleming@jhu.edu.

Funding

Program of Molecular BiophysicsT32GM135131 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI Karen G. Fleming · 2020 to 2026
$5.4M
Forces Driving Membrane Protein FoldsR35GM148199 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI Karen G. Fleming · 2023 to 2026
$1.9M
NIGMS NIH HHS R35 GM148199NIGMS NIH HHS T32 GM135131
6 · The paper itself

Abstract

Polyethylene glycol (PEG) conjugation provides a protective modification that enhances the pharmacokinetics and solubility of proteins for therapeutic use. A knowledge of the structural ensemble of these PEGylated proteins is necessary to understand the molecular details that contribute to their hydrodynamic and colligative properties. Because of the large size and dynamic flexibility of pharmaceutically important PEGylated proteins, the determination of structure is challenging. In addition, the hydration of these conjugates that contain large polymers is difficult to determine with traditional methods that identify only first shell hydration water, which does not account for the complete hydrodynamic volume of a macromolecule. Here, we demonstrate that structural ensembles, generated by coarse-grained simulations, can be analyzed with HullRad and used to predict sedimentation coefficients and concentration-dependent hydrodynamic and diffusion nonideality coefficients of PEGylated proteins. A knowledge of these concentration-dependent properties enhances the ability to design and analyze new modified protein therapeutics. HullRad accomplishes this analysis by effectively accounting for the complete hydration of a macromolecule, including that of flexible polymers.

Indexed as

HydrodynamicsPolyethylene GlycolsDiffusionHumansMolecular Dynamics SimulationSerum Albumin, HumanWaterPolyethylene GlycolsSerum Albumin, HumanWater

Identifiers

PMID38778541
PMCPMC11365107

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.